X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (31) 31
index medicus (24) 24
immunology (23) 23
immunotherapy (20) 20
cancer (16) 16
oncology (15) 15
t cells (15) 15
cd8-positive t-lymphocytes - immunology (14) 14
peptides (14) 14
animals (12) 12
chemistry (12) 12
lymphocytes (12) 12
vaccination (12) 12
antigens, neoplasm - immunology (11) 11
female (11) 11
melanoma - immunology (10) 10
metallurgy (10) 10
mice (10) 10
organic chemistry (10) 10
biochemistry (9) 9
neoplasm proteins - immunology (9) 9
tumors (9) 9
beer (8) 8
bladder cancer (8) 8
enzymology (8) 8
expression (8) 8
human necessities (8) 8
hygiene (8) 8
medical or veterinary science (8) 8
microbiology (8) 8
mutation or genetic engineering (8) 8
preparations for medical, dental, or toilet purposes (8) 8
spirits (8) 8
vinegar (8) 8
wine (8) 8
antigens (7) 7
bcg (7) 7
compositions thereof (7) 7
culture media (7) 7
melanoma (7) 7
melanoma - therapy (7) 7
microorganisms or enzymes (7) 7
propagating, preserving or maintaining microorganisms (7) 7
specific therapeutic activity of chemical compounds ormedicinal preparations (7) 7
activation (6) 6
cd8-positive t-lymphocytes - metabolism (6) 6
clone cells (6) 6
responses (6) 6
urinary bladder neoplasms - immunology (6) 6
cell line, tumor (5) 5
chemical and pharmacologic phenomena (5) 5
cos cells (5) 5
epitopes, t-lymphocyte - immunology (5) 5
genital mucosa (5) 5
health aspects (5) 5
immunization (5) 5
immunotherapy - methods (5) 5
mart-1 antigen (5) 5
peptide fragments - immunology (5) 5
research (5) 5
t cell receptors (5) 5
therapy (5) 5
abridged index medicus (4) 4
aged (4) 4
article (4) 4
bacillus-calmette-guerin (4) 4
btla (4) 4
cancer vaccines (4) 4
care and treatment (4) 4
cell proliferation (4) 4
dendritic cells (4) 4
herpesvirus entry mediator (4) 4
immune-responses (4) 4
life sciences (4) 4
lymphocytes t (4) 4
male (4) 4
memory (4) 4
middle aged (4) 4
multidisciplinary sciences (4) 4
proteins (4) 4
testing (4) 4
urinary bladder neoplasms - pathology (4) 4
urinary bladder neoplasms - therapy (4) 4
urology (4) 4
urology & nephrology (4) 4
vaccines (4) 4
adjuvants, immunologic - pharmacology (3) 3
administration, intravesical (3) 3
amino acid sequence (3) 3
antigen (3) 3
antigen presentation (3) 3
antigens, neoplasm - chemistry (3) 3
b-lymphocyte (3) 3
bacterial immunostimulant (3) 3
bcg therapy (3) 3
biology (3) 3
brief report (3) 3
cancer therapies (3) 3
cancer vaccines - immunology (3) 3
cd8 (3) 3
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Cancer Immunology, Immunotherapy, ISSN 0340-7004, 4/2013, Volume 62, Issue 4, pp. 747 - 760
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 02/2017, Volume 23, Issue 3, pp. 717 - 725
Purpose: Treatments with cancer vaccines may be delivered as combination therapies for better efficacy. Addition of intravesical immunostimulation with... 
TRIAL | IMMUNOGENICITY | ONCOLOGY | IMMUNOTHERAPY | UROTHELIAL CARCINOMA | BCG | TUMOR-REGRESSION | EAU GUIDELINES | PHASE-II | MAGE-A3 | IMIQUIMOD | Immunotherapy - methods | Oligodeoxyribonucleotides - administration & dosage | Adjuvants, Immunologic - administration & dosage | Dose-Response Relationship, Immunologic | Humans | Lipid A - analogs & derivatives | Neoplasm Proteins - immunology | Carcinoma, Transitional Cell - therapy | Plant Extracts - administration & dosage | Cancer Vaccines - therapeutic use | Urinary Bladder Neoplasms - pathology | Immunization Schedule | Quillaja | Lipid A - administration & dosage | Cytokines - urine | Antigens, Neoplasm - immunology | Cancer Vaccines - administration & dosage | Cancer Vaccines - adverse effects | Combined Modality Therapy | Injections, Intramuscular | Lymphocytes, Tumor-Infiltrating - drug effects | Urinary Bladder Neoplasms - surgery | Carcinoma, Transitional Cell - pathology | Recombinant Proteins - immunology | Carcinoma, Transitional Cell - immunology | BCG Vaccine - adverse effects | Urinary Bladder Neoplasms - therapy | Urinary Bladder Neoplasms - immunology | Administration, Intravesical | BCG Vaccine - therapeutic use | Carcinoma, Transitional Cell - surgery | BCG Vaccine - administration & dosage | Cystectomy - methods | Therapy | Animal models | Drug delivery systems | Vaccination | Bladder | Lymphocytes T | Vaccines | Cancer therapies | Blood | Metastases | Cancer vaccines | Urinary bladder | Lymphocytes | Safety engineering | Combined vaccines | Bacteria | Urine | Immune response | Immunostimulation | Invasiveness | Muscles | Adjuvants | Regression analysis | Patients | Bladder cancer | Experimental design | Infiltration | Cancer
Journal Article
PLoS ONE, ISSN 1932-6203, 06/2017, Volume 12, Issue 6, p. e0179201
Antibody based immune-checkpoint blockade therapy is a major breakthrough in oncology, leading to clinical benefit for cancer patients. Among the growing... 
UNTREATED MELANOMA | B-LYMPHOCYTE | ACTIVATION | HERPESVIRUS ENTRY MEDIATOR | MULTIDISCIPLINARY SCIENCES | LYMPHOCYTE ATTENUATOR | BTLA | RECEPTOR | CANCER-IMMUNOTHERAPY | IPILIMUMAB | CHECKPOINT BLOCKADE | Amino Acid Sequence | Cell Line | Receptors, Immunologic - chemistry | Peptides - chemistry | Humans | Receptors, Tumor Necrosis Factor, Member 14 - chemistry | Neoplasms - drug therapy | Peptides - pharmacology | Receptors, Tumor Necrosis Factor, Member 14 - metabolism | Peptides - chemical synthesis | Neoplasms - immunology | T-Lymphocytes - drug effects | Protein Binding - drug effects | Drug Design | T-Lymphocytes - immunology | Cysteine - metabolism | Neoplasms - pathology | Peptides - therapeutic use | Receptors, Immunologic - metabolism | Usage | Cancer patients | Care and treatment | Peptides | Lymphocytes | Immunotherapy | Research | T cells | Cell proliferation | Therapy | Cysteine | Herpes simplex | Viruses | Oncology | Lymphocytes T | Design analysis | Assaying | Cancer therapies | Urology | Fragmentation | Design | Analogs | Proteins | Receptors | Cell growth | BTLA protein | Attenuation | Bioinformatics | Enzyme-linked immunosorbent assay | Crystal structure | Binding | Medical research | Antigens | Immunoglobulins | Melanoma | Blocking | T cell receptors | Patients | Immune checkpoint | Lymphocytes B | Ligands | In vitro methods and tests | Cancer | Medicinal Chemistry | Life Sciences | Immunology | Chemical Sciences
Journal Article
Journal of Clinical Investigation, ISSN 0021-9738, 08/2017, Volume 127, Issue 8, pp. 2916 - 2929
Journal Article
Nature reviews. Urology, ISSN 1759-4812, 09/2019, Volume 16, Issue 10, pp. 613 - 630
Bladder cancer is an important public health concern owing to its prevalence, high recurrence risk and treatment failures. Maintaining the equilibrium between... 
Journal Article
Nature Communications, ISSN 2041-1723, 12/2018, Volume 9, Issue 1, pp. 1092 - 10
Journal Article
Journal Article
PLoS ONE, ISSN 1932-6203, 2011, Volume 6, Issue 10, p. e26301
Journal Article
PLoS ONE, ISSN 1932-6203, 06/2017, Volume 12, Issue 6
Antibody based immune-checkpoint blockade therapy is a major breakthrough in oncology, leading to clinical benefit for cancer patients. Among the growing... 
Life Sciences
Journal Article
Seminars in Immunology, ISSN 1044-5323, 02/2019, Volume 41, p. 101276
Group 2 innate lymphoid cells (ILC2s) are critical for the initiation of type 2 inflammatory diseases. However, ILC2s are also involved in the establishment of... 
ILC2 | Group-2 innate lymphoid cells | Tumor immunoregulation | Cancer
Journal Article
Journal Article